Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 17 911 21 893 18 750 19 356 20 558 21 793
EBITDA 3 413 3 814 4 234 4 270 4 276 4 557
Operating profit (EBIT) 2 638 2 908 3 442 2 553 2 817 3 092
Pre-Tax Profit (EBT) 2 232 2 472 3 101 2 051 2 392 2 692
Net income 1 243 1 576 2 246 1 311 1 522 1 705
P/E ratio 20,8x 20,5x 8,86x 17,3x 14,6x 13,1x
EPS ( $ ) 4,07 5,13 7,33 4,35 5,15 5,75
Dividend per Share ( $ ) 1,01 1,18 1,33 1,29 1,37 1,48
Yield 1,20% 1,12% 2,04% 1,71% 1,82% 1,97%
Reference price ( $ ) 84,601 105,306 64,943 75,243 75,243 75,243
Announcement Date 02/22/2017
06:09am
02/26/2018
09:56pm
02/20/2019
06:24am
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt 7 824 7 920 6 135 12 688 11 877 10 706
Finance - - - - - -
Operating income (EBITDA) 3 413 3 814 4 234 4 270 4 276 4 557
Leverage
(Debt/EBITDA)
2,29x 2,08x 1,45x 2,97x 2,78x 2,35x
Capital Expenditure 1 030 1 156 1 201 1 190 1 231 1 332
Free Cash Flow (FCF) 1 110 1 527 1 142 1 329 1 722 2 022
Book Value Per Share (BVPS) ( $ ) 35,3 39,2 43,1 44,6 48,1 52,4
Cash Flow per Share ( $ ) 6,99 8,73 7,64 8,79 9,48 9,90
Announcement Date 02/22/2017
06:09am
02/26/2018
09:56pm
02/20/2019
06:24am
- - -
Balance Sheet Analysis
Assessed data source
© 2020 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 22 435 M $ -
Entreprise Value (EV) 35 123 M $ 34 312 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) 17,3x 14,6x
Capitalization / Revenue 1,16x 1,09x
EV / Revenue 1,81x 1,71x
EV / EBITDA 8,23x 8,21x
Yield (DPS / Price) 1,71% 1,82%
Price to book (Price / BVPS) 1,69x 1,56x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 13,2% 13,7%
Operating Leverage (Delta EBIT / Delta Sales) - 1,66x
Net Margin (Net Profit / Revenue) 6,77% 7,41%
ROA (Net Profit / Asset) 4,40% 4,78%
ROE (Net Profit / Equities) 10,5% 10,9%
Rate of Dividend 29,6% 26,6%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   6,15% 5,99%
Cash Flow / Sales 13,5% 13,7%
Capital Intensity (Assets / Sales) 1,54x 1,55x
Financial Leverage (Net Debt / EBITDA) 2,97x 2,78x
EPS & Dividend